Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis

There are concerns by the United States Food and Drug Administration (FDA) regarding a potential link between tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF‐TKIs) and the risk of aortic dissection. Elevation of blood pressure induced by VEGF‐TKIs has been discussed as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Res Perspect
Main Authors: Dörks, Michael, Jobski, Kathrin, Herget‐Rosenthal, Stefan, Hoffmann, Falk, Douros, Antonios
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Short Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796803/
https://ncbi.nlm.nih.gov/pubmed/33421342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.707
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares